The Role of TYK2 Inhibitors in the Pathogenesis and Treatment of Psoriasis. (PubMed, J Clin Aesthet Dermatol) - Sep 20, 2026 - "TYK2 inhibition represents a significant advancement for the treatment of psoriasis. Continued research will enable optimization of these agents in managing psoriasis and related immune-mediated diseases."
Journal • Review • Dermatology • Immunology • Psoriasis • TYK2
|
|
Joshua Burshtein; Todd Schlesinger
|